Literature DB >> 25337407

Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.

Adam Maciejczyk1, Iga Skrzypczyńska1, Marzena Janiszewska2.   

Abstract

This survey is performed to update knowledge about methods and trends in lung cancer radiotherapy. A significant development has been noticed in radiotherapeutic techniques, but also in the identification of clinical prognostic factors. The improvement in the therapeutic line includes: application of the four-dimensional computer tomography (4DCT), taking advantage of positron emission tomography (PET-CT), designing of new computational algorithms, allowing more precise irradiation planning, development of treatment precision verification systems and introducing IMRT techniques in chest radiotherapy. The treatment outcomes have improved with high dose radiotherapy, but other fractionation alternations have been investigated as well.

Entities:  

Keywords:  Lung cancer; Radiotherapy; SBRT

Year:  2014        PMID: 25337407      PMCID: PMC4201776          DOI: 10.1016/j.rpor.2014.04.012

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  42 in total

Review 1.  European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

Authors:  Dirk De Ruysscher; Corinne Faivre-Finn; Ursula Nestle; Coen W Hurkmans; Cécile Le Péchoux; Allan Price; Suresh Senan
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

2.  Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer.

Authors:  René W M Underberg; Frank J Lagerwaard; Ben J Slotman; Johan P Cuijpers; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

3.  Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience.

Authors:  Bedatri Sinha; Ronald C McGarry
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

Review 4.  Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.

Authors:  Robert Timmerman; James Galvin; Jeff Michalski; William Straube; Geoffrey Ibbott; Elizabeth Martin; Ramzi Abdulrahman; Suzanne Swann; Jack Fowler; Hak Choy
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

5.  Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.

Authors:  Milena Kolodziejczyk; Lucyna Kepka; Miroslaw Dziuk; Anna Zawadzka; Norbert Szalus; Agnieszka Gizewska; Krzysztof Bujko
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-23       Impact factor: 7.038

Review 6.  Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review.

Authors:  Angela van Baardwijk; Wolfgang A Tomé; Wouter van Elmpt; Søren M Bentzen; Bart Reymen; Rinus Wanders; Ruud Houben; Michel Ollers; Philippe Lambin; Dirk De Ruysscher
Journal:  Radiother Oncol       Date:  2012-10-12       Impact factor: 6.280

Review 7.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.

Authors:  Alexander Chi; Zhongxing Liao; Nam P Nguyen; Jiahong Xu; Baldassarre Stea; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2010-01-13       Impact factor: 6.280

8.  Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.

Authors:  Cornelis J A Haasbeek; Frank J Lagerwaard; Katrien de Jaeger; Ben J Slotman; Suresh Senan
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

Review 9.  New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.

Authors:  Joseph K Salama; Everett E Vokes
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

Review 10.  Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review.

Authors:  Sashendra Senthi; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2013-02-22       Impact factor: 6.280

View more
  10 in total

1.  Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.

Authors:  Semi B Harrabi; Stefan A Koerber; Sebastian Adeberg; Sonja Katayama; Klaus Herfarth; Juergen Debus; Florian Sterzing
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-11

2.  Development of a novel detection method for changes in lung conditions during radiotherapy using a temporal subtraction technique.

Authors:  Yoshinori Tanabe; Takayuki Ishida
Journal:  Phys Eng Sci Med       Date:  2021-10-26

3.  Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells.

Authors:  Lucie Sancey; Odile Sabido; Zhiguo He; Fabien Rossetti; Alain Guignandon; Valérie Bin; Jean-Luc Coll; Michèle Cottier; François Lux; Olivier Tillement; Samuel Constant; Christophe Mas; Delphine Boudard
Journal:  J Nanobiotechnology       Date:  2020-09-10       Impact factor: 10.435

Review 4.  A review of automatic lung tumour segmentation in the era of 4DCT.

Authors:  Nadine Wong Yuzhen; Sarah Barrett
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-22

5.  Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer.

Authors:  John M Watkins; J Kyle Russo; Nicholas Andresen; Coyt R Rountree; Amir Zahra; Sarah L Mott; Daniel J Herr; Jacy O'Keefe; Bryan G Allen; Anand K Sharma; John M Buatti
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

6.  Impact of deformable image registration on dose accumulation applied electrocardiograph-gated 4DCT in the heart and left ventricular myocardium during esophageal cancer radiotherapy.

Authors:  Ying Tong; Yong Yin; Pinjing Cheng; Guanzhong Gong
Journal:  Radiat Oncol       Date:  2018-08-10       Impact factor: 3.481

7.  Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer.

Authors:  Liguang Wang; Kai Wang; Wei Dong; Hongchang Shen; Jiajun Du
Journal:  J Cancer       Date:  2019-07-08       Impact factor: 4.207

8.  Verification of an optimizer algorithm by the beam delivery evaluation of intensity-modulated arc therapy plans.

Authors:  Tamas Pocza; Domonkos Szegedi; Tibor Major; Csilla Pesznyak
Journal:  Radiol Oncol       Date:  2021-11-19       Impact factor: 2.991

9.  The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.

Authors:  Kun Zou; Caigang Liu; Zhuo Zhang; Lijuan Zou
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

10.  Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells.

Authors:  Hyejin Park; Ye Ji Jeong; Na-Kyung Han; Joong Sun Kim; Hae-June Lee
Journal:  Int J Mol Sci       Date:  2018-08-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.